Qiming U.S. Ventures Management, LLC Hille Vax, Inc. Transaction History
Qiming U.S. Ventures Management, LLC
- $9.53 Million
- Q2 2024
A detailed history of Qiming U.S. Ventures Management, LLC transactions in Hille Vax, Inc. stock. As of the latest transaction made, Qiming U.S. Ventures Management, LLC holds 558,923 shares of HLVX stock, worth $1.02 Million. This represents 84.8% of its overall portfolio holdings.
Number of Shares
558,923
Previous 558,923
-0.0%
Holding current value
$1.02 Million
Previous $9.29 Million
13.04%
% of portfolio
84.8%
Previous 75.52%
Shares
1 transactions
Others Institutions Holding HLVX
# of Institutions
96Shares Held
41MCall Options Held
0Put Options Held
0-
Frazier Life Sciences Management, L.P. Menlo Park, CA10.6MShares$19.3 Million9.05% of portfolio
-
Deerfield Management Company, L.P. (Series C) New York, NY4MShares$7.29 Million1.22% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.48MShares$6.34 Million0.03% of portfolio
-
Black Rock Inc. New York, NY2.09MShares$3.8 Million0.0% of portfolio
-
Franklin Resources Inc San Mateo, CA1.99MShares$3.62 Million0.01% of portfolio
About HilleVax, Inc.
- Ticker HLVX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 33,427,200
- Market Cap $60.8M
- Description
- HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines. It is developing HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company is headquartered in Boston, Massachusetts.